knowledge -WSS

knowledge

author：fashion 2025-09-06 04:36:25 - browse：245

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Companies helping big Covid

explore

WSS

Scrutiny of post

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

FDA poised to publish guidelines for clinical trial diversity

Watch the official trailer for 'Ahsoka' series

EU fines Illumina $475 million over Grail acquisition

Antibody drugs appear effective. Now can we make enough of them?

focus

knowledge

hotspot

Continuity nursing helped my family in our darkest PICU moments

Addressing health care workers' trauma can help fight burnout

United colonoscopy coverage change 'may cost lives,' doctors say

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

State Dept. review finds Biden bears some blame for Afghanistan failures

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Anesthesiologist group: stop taking Ozempic before surgery

After half a century, Israel moves to evict squatter from his cave home on the beach

Dobbs anniversary: the lost opportunity of abortion as health care

Listen: More tumult at BIO & coercive care for sickle cell patients

focus

Inflation cooled significantly in June, bringing price hikes close to normal levels

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Cue Health, Covid

One Duchenne patient's bittersweet hope for new treatment

Sickle cell gene therapy cures need to be accessible in Africa

knowledge

Wikipedia

explore

explore